Loading clinical trials...
Loading clinical trials...
An Open, Randomized, Two-way Cross-over Phase I Study to Compare the Bioavailability, Safety and Tolerability of Single s.c. Doses of 300 IU XM17 With 300 IU Gonal-f® in 36 Healthy, Down-regulated Young Women
Conditions
Interventions
XM17
Gonal-f®
+1 more
Start Date
February 1, 2009
Primary Completion Date
May 1, 2009
Completion Date
December 1, 2009
Last Updated
November 9, 2021
NCT07345130
NCT06969963
NCT06924190
NCT06830954
NCT06758531
NCT06600282
Lead Sponsor
Merckle GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions